| P50 | author | Lukasz Laczmanski | Q87614936 |
| | Paweł Krzyżek | Q90113239 |
| | Pawel Migdal | Q90757667 |
| | Grażyna Gościniak | Q91253602 |
| | Roman Franiczek | Q91713760 |
| | Barbara Krzyżanowska | Q91713763 |
| P2860 | cites work | The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. | Q38837920 |
| | Effect of 3-bromopyruvate and atovaquone on infection during in vitro interaction of Toxoplasma gondii and LLC-MK2 cells. | Q38863836 |
| | Inhibitory effects of 3-bromopyruvate on human gastric cancer implant tumors in nude mice | Q38996349 |
| | Quantifying membrane permeability of amphotericin B ion channels in single living cells | Q39438994 |
| | Multiparameter flow cytometric analysis of antibiotic effects on membrane potential, membrane permeability, and bacterial counts of Staphylococcus aureus and Micrococcus luteus | Q39473354 |
| | In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori | Q39474501 |
| | Frequency of infection with Helicobacter pylori isolates of different antimicrobial profiles in children and adolescents: A preliminary study. | Q40089568 |
| | Role of Helicobacter pylori coccoid forms in infection and recrudescence | Q41151840 |
| | The Mycobacterium tuberculosis H37Ra gene MRA_1916 causes growth defects upon down-regulation | Q41990490 |
| | Morphological and Bactericidal Effects of Different Antibiotics on Helicobacter pylori. | Q42154318 |
| | Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods | Q43928980 |
| | Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK. | Q45933625 |
| | Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption | Q46953063 |
| | Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori | Q46978428 |
| | Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. | Q47765000 |
| | Helicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression. | Q49228602 |
| | Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development | Q50083339 |
| | Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors | Q24530627 |
| | Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review | Q26785651 |
| | Helicobacter pylori virulence and cancer pathogenesis | Q27013699 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 |
| | The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate | Q28073392 |
| | Growth inhibitory, bactericidal, and morphostructural effects of dehydrocostus lactone from Magnolia sieboldii Leaves on antibiotic-susceptible and -resistant strains of Helicobacter pylori | Q28538045 |
| | Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations | Q31138535 |
| | Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development | Q33594937 |
| | The importance of the viable but non-culturable state in human bacterial pathogens | Q33696026 |
| | Glucose catabolism in African trypanosomes. Evidence that the terminal step is catalyzed by a pyruvate transporter capable of facilitating uptake of toxic analogs. | Q34360049 |
| | Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase | Q34517998 |
| | Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. | Q34542021 |
| | Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pylori. | Q34713744 |
| | Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat model | Q34834980 |
| | Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned? | Q34983201 |
| | Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis. | Q35615105 |
| | Pharmacodynamics of antimicrobial drugs | Q35861670 |
| | Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention | Q36120729 |
| | Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori | Q36207858 |
| | Fabrication of Te and Te-Au Nanowires-Based Carbon Fiber Fabrics for Antibacterial Applications. | Q36633859 |
| | A T4SS Effector Targets Host Cell Alpha-Enolase Contributing to Brucella abortus Intracellular Lifestyle | Q37416146 |
| | Helicobacter pylori: a chameleon-like approach to life | Q38219015 |
| | Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori | Q38459495 |
| | 3-Bromopyruvate and sodium citrate induce apoptosis in human gastric cancer cell line MGC-803 by inhibiting glycolysis and promoting mitochondria-regulated apoptosis pathway | Q38772005 |
| | Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. | Q38812758 |
| | Synthesis of New Nitrofluoroquinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant H. pylori. | Q51216432 |
| | In vitro activity of Aloe vera inner gel against Helicobacter pylori strains. | Q51750306 |
| | In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid. | Q52682304 |
| | 3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis. | Q53688064 |
| | Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial | Q57213244 |
| | Morphology of as a result of peptidoglycan and cytoskeleton rearrangements | Q57301730 |
| | Intraarterial Therapy with a New Potent Inhibitor of Tumor Metabolism (3-bromopyruvate): Identification of Therapeutic Dose and Method of Injection in an Animal Model of Liver Cancer | Q60531739 |
| | Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae | Q62663288 |
| | Intensive formation of coccoid forms as a feature strongly associated with highly pathogenic Helicobacter pylori strains. | Q64949211 |
| | Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994 | Q72152032 |
| | Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response | Q77544463 |
| | Activities of muscadine grape skin and polyphenolic constituents against Helicobacter pylori | Q85845555 |
| | 3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans | Q86509297 |
| | Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions | Q89499049 |
| | Induction of Different Sensitization Patterns of MRSA to Antibiotics Using Electroporation | Q90419708 |
| | The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus | Q93345255 |
| | The antimicrobial susceptibility of Helicobacter pylori strains isolated from children and adults with primary infection in the Lower Silesia Region, Poland | Q95444547 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 229 | |
| P577 | publication date | 2019-02-15 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains | |
| P478 | volume | 11 | |